Fresh research from McKinsey suggesting AI can create more roles than it replaces has pushed artificial intelligence back into the spotlight for Canadian investors. That kind of long runway for adoption matters when AI is plugged into healthcare, where better data and faster decisions can directly affect lives and costs. This article walks through three Canadian AI healthcare stocks from our screener that illustrate different ways to tap into that potential.
The three stocks below are just a sample set from that theme, and the full screen surfaced 4 more healthcare AI companies with equally compelling narratives that are not covered here. To identify, compare, and analyze those extra candidates alongside the stocks in this article, head straight into the Transformative Artificial intelligence (AI) Healthcare Stocks screener .
Profound Medical (TSX:PRN)
Overview:Profound Medical develops AI-powered, MRI-guided systems like TULSA-PRO and Sonalleve that deliver incision-free, targeted ablation of diseased tissue.
Operations:Profound Medical generates about $19 million from medical technology devices, with roughly $12 million in the USA and $6 million in Canada.
Market Cap:$359 million
Profound Medical ties directly into AI healthcare through its MRI-guided, robotically controlled TULSA-PRO platform, which uses AI-driven imaging and temperature feedback to focus prostate ablation. The business remains loss making while it scales, although recent revenue and loss figures show movement toward lower cash burn. Investor interest hinges on how adoption of this AI-guided procedure affects demand and pricing if a single key assumption breaks.
If that assumption matters to your thesis on Profound Medical, explore the 1 key reward and 1 important warning sign for a closer look at what could accelerate or stall the story.
Healwell AI (TSX:AIDX)
Overview:Healwell AI builds clinical decision support systems and AI engines that help detect rare and chronic diseases and guide treatment choices for healthcare organizations.
Operations:Healwell AI generates about $119 million from healthcare software and $10 million from AI and data sciences, mostly in Australia and New Zealand.
Market Cap:$225 million
Where Profound Medical applies artificial intelligence to procedure guidance, Healwell AI focuses on the data layer, turning electronic records into decision tools that aim to reduce missed diagnoses and lighten clinician workload.
"The vast and growing pool of digitized healthcare data, strengthened by ongoing adoption of telemedicine and electronic health records worldwide, could affect the training and effectiveness of Healwell's AI models and the launch of next-generation clinical decision tools, with potential implications for pricing and SaaS revenue streams."
What happens to Healwell AI's upside if the expected shift toward higher margin, recurring AI software contracts unfolds more slowly than some investors expect?
If that shift in revenue mix is what you keep circling back to, read the full narrative for Healwell AI to see how pricing power and AI adoption could be decoupling.
Perimeter Medical Imaging AI (TSXV:PINK)
Overview:Perimeter Medical Imaging AI develops OCT imaging systems and AI tools like Claire OCT with ImgAssist to give surgeons real-time margin assessment during breast cancer procedures.
Operations:Perimeter Medical Imaging AI generates about $2 million from medical imaging systems, with revenue currently reported entirely from Canada.
Market Cap:$34 million
Perimeter Medical Imaging AI fits this AI healthcare theme because its Claire OCT with ImgAssist brings machine learning straight into the operating room, offering real-time tissue insights during breast conserving surgery. At the same time, revenue and cash runway remain tight, and investor interest depends on how demand for this intraoperative AI tool develops if a single key assumption changes.
That inflection point is exactly why many investors are now turning to the 2 key rewards and 3 important warning signs (1 is major!) to evaluate where Perimeter Medical Imaging AI's upside could exceed its funding risks.
Seeking Fresh Alternatives Before Others
Fresh ideas move first, then the crowd follows and the easy entries close. Catch potential breakout stories while momentum is still forming and data is fresh. Get in early.
-
Track where cash strength meets potential upside by scanning a curated list of solid balance sheet and fundamentals (7 results) that highlights businesses with room to move before wider attention arrives.
-
Spot early shifts in enterprise tech by zeroing in on a hand picked set of 92 AI infrastructure stocks that could gain momentum as demand builds.
-
Target companies riding long term hardware and software automation with a focused group of 91 robotics and automation stocks chosen for staying power rather than short lived hype.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
